Reset filters
  • 18 November 2013

AbbVie reports 96% cure rate for interferon-free hepatitis C regimen in phase 3 study

Read the article
  • 18 November 2013

Church attendance associated with late HIV diagnosis among US MSM

Read the article
  • 15 November 2013

GAT Portugal

Read the article
GAT Portugal
  • 15 November 2013

Successful hepatitis C treatment reduces risk of liver cancer and death, but most remain untreated

Read the article
HCV treatment cascade illustration, part of the presentation by Ronald Valdiserri, US Deputy Assistant Secretary for Health, at The Liver Meeting 2013.
  • 15 November 2013

Harm reduction works: extremely low HIV incidence over almost 20 years among people who inject drugs in Australia

Read the article
  • 14 November 2013

Sofosbuvir/ribavirin for 24 weeks cures most genotype 3 hepatitis C patients, adding interferon may help difficult-to-treat

Read the article
  • 13 November 2013

Faldaprevir plus pegylated interferon/ribavirin leads to early sustained response in people with HIV and HCV co-infection

Read the article
  • 13 November 2013

Rifampicin dose can be increased safely in TB treatment, may shorten duration

Read the article
  • 12 November 2013

Audit shows many high HIV prevalence areas in England are failing to expand HIV testing

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.